Small interference RNA targeting heat‐shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase‐3 activation in vitro
- 9 October 2006
- journal article
- Published by Wiley in BJU International
- Vol. 98 (5), 1082-1089
- https://doi.org/10.1111/j.1464-410x.2006.06425.x
Abstract
OBJECTIVES To evaluate synthetic small interference RNA (siRNA) compounds targeting heat-shock protein 27 (Hsp27) as an alternative approach to Hsp27 ‘knockdown’ in prostate cancer cells, as Hsp27 expression is highly up-regulated in prostate cancer cells after androgen withdrawal or chemotherapy, to become uniformly highly expressed in androgen-independent (AI) prostate cancer. MATERIALS AND METHODS We recently showed that targeting Hsp27 by a 2′-methoxyethyl modified phosphorothioate antisense oligonucleotide, OGX-427, inhibits Hsp27 expression and enhances hormone- and chemotherapy in prostate cancer xenograft models. In the present study, a ‘gene walk’ screening different siRNAs was initially used in PC-3 and LNCaP cells to determine the most potent sequence to down-regulate Hsp27 mRNA and protein levels. The effects of Hsp27 silencing on in vitro growth rates were studied by tetrazolium-blue and crystal violet assays. Apoptosis was determined by single-stranded DNA nuclear and cleaved caspase-3 immunostaining, as well as flow cytometry. Spotted microarrays with 14000 human oligonucleotides were used to examine changes in gene expression. RESULTS Low concentrations of 1 nm siRNA decreased Hsp27 mRNA levels by 19-fold and suppressed protein expression to undetectable levels. Silencing of Hsp27 in prostate cancer cells by siRNA♯2 increased apoptotic rates 2.4–4 fold and caused 40–76% inhibition of cell growth in LNCaP and PC-3 cells. Characteristic cleavage of caspase-3 occurred after treatment with Hsp27 siRNA (1 nm). cDNA microarray analysis from LNCaP and PC-3 cell lines revealed differential gene expression profiles after Hsp27 down-regulation that could be used to identify various survival pathways involved in androgen-dependent and AI growth. CONCLUSIONS These findings illustrate the potential utility of Hsp27-silencing therapy and highlight Hsp27 siRNA strategies as a novel and highly effective tool, with the potential for future targeted therapy in enhancing the efficacy of chemotherapy in advanced prostate cancer.Keywords
This publication has 26 references indexed in Scilit:
- Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograftOncogene, 2004
- Essential Role of the NH2-terminal WD/EPF Motif in the Phosphorylation-activated Protective Function of Mammalian Hsp27Published by Elsevier BV ,2004
- Development of prostate cancer treatment: The good newsThe Prostate, 2004
- Gene silencing in mammals by small interfering RNAsNature Reviews Genetics, 2002
- Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivoOncogene, 2000
- Inconstant Association between 27‐kDa Heat‐Shock Protein (Hsp27) Content and Doxorubicin Resistance in Human Colon Cancer CellsJBIC Journal of Biological Inorganic Chemistry, 1996
- Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancerThe Prostate, 1996
- Characterization of 45‐kDa/54‐kDa HSP27 Kinase, a Stress‐Sensitive Kinase Which may Activate the Phosphorylation‐Dependent Protective Function of Mammalian 27‐kDa Heat‐shock Protein HSP27JBIC Journal of Biological Inorganic Chemistry, 1995
- The serum‐induced phosphorylation of mammalian hsp27 correlates with changes in its intracellular localization and levels of oligomerizationJBIC Journal of Biological Inorganic Chemistry, 1994
- Phosphorylation of HSP27 during development and decay of thermotolerance in Chinese hamster cellsJournal of Cellular Physiology, 1991